companies innovating in obesity treatment glp-1 drugs 2025 Pipeline Update: August - Prime Therapeutics GLP-1 Agonists Weight Loss Drugs

Another condition that may contribute to FGID in FM patients is non-celiac wheat sensitivity (NCWS) [35], a condition in which GI and extraintestinal symptoms are triggered by wheat in the absence of celiac disease (CD) or wheat allergy

RESULTS: Total serum glutathione levels increased by an average of 25% over 4 weeks

Nigella sativa Its active compound, thymoquinone, exhibits anti-oxidant properties, which could be beneficial in treating psoriasis by addressing the oxidant-anti-oxidant imbalance regularly present in psoriasis

Insights into a possible role of glucagon-like Peptide-1 receptor agonists in the treatment of depression

The mental fog that accompanies aging, poor sleep, or chronic stress starts lifting